Research Group "Molecular regulation of B-cell development"
Prof. Dr. Hermann EibelOur group focuses on the development of human B cells and primary immune defects affecting B lymphocytes. Together with Klaus Warnatz and Uli Salzer we found that homozygous deletion of the BAFF-receptor gene may cause common variable immunodeficiency.
Hermann Eibel
Group Leader, Head of Clinical Research Unit for Rheumatology
| since 2000 | Habilitation in Molecular Immunology at the Faculty of Biology, Albert-Ludwigs-University Freiburg |
| since 1992 | Head of Clinical Research Unit for Rheumatology, University Medical Center Freiburg, Dept. of Rheumatology and Clinical Immunology |
| 1985 - 1992 | Group Leader, Max-Planck-Institute for Immunobiology, Freiburg, Department of Prof. Georges Köhler (PhD) |
| 1983 - 1985 | Postdoctoral Research Fellow, Albert-Ludwigs-University Freiburg, Institute for Biology |
| 1979 - 1982 | Ph.D. Thesis Student, Biocenter, University of Basel, Switzerland |
| 1974 - 1979 | Diploma in Biology II, Biocenter, University of Basel, Switzerland |
Contact
Prof. Dr. phil. nat. Hermann Eibel
MEDICAL CENTER - UNIVERSITY OF FREIBURG
Center for Chronic Immunodeficiency
at Center for Translational Cell Research
Breisacher Str. 115
79106 Freiburg
Germany
Phone: +49 (0)761 270-77752
Fax: +49 (0)761 270-77753
hermann.eibel@uniklinik-freiburg.de